Clinical trial
Higher VO2max Delays Substrate Switching and Shifts the Crossover Point to Greater Oxygen Uptake During Incremental Exerciseebys
NCT07799662 is registered in ClinicalTrials.gov with Celil Kaçoğlu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Higher VO2max Delays Substrate Switching and Shifts the Crossover Point to Greater Oxygen Uptake During Incremental Exerciseebys
- Lead sponsor
- Celil Kaçoğlu
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 1, 2026
- Completion date
- July 15, 2026
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiorespiratory fitness, maximal oxygen uptake, metabolic flexibility, substrate metabolism during exercise